These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33571371)

  • 61. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
    Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA
    Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunohistochemistry of mammary Paget's disease. Cytokeratin 7, GATA3, and HER2 are sensitive markers.
    Arain SA; Arafah M; Said Raddaoui EM; Tulba A; Alkhawaja FH; Al Shedoukhy A
    Saudi Med J; 2020 Mar; 41(3):232-237. PubMed ID: 32114594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas.
    Prabhakaran S; Hocking A; Kim C; Hussey M; Klebe S
    Hum Pathol; 2020 Nov; 105():1-8. PubMed ID: 32888937
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predictive parameters for internal mammary node drainage in patients with early breast cancer.
    Lukesova L; Vrana D; Gatek J; Koranda P; Cwiertka K; Radova L; Melichar B; Prouzova Z; Sramek V; Svach I
    Tumori; 2014; 100(3):254-8. PubMed ID: 25076234
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis.
    Ding J; Jiang L; Gan Y; Wu W
    Int J Clin Exp Pathol; 2015; 8(3):3322-7. PubMed ID: 26045861
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression patterns of GATA3 and the androgen receptor are strongly correlated in patients with triple-negative breast cancer.
    Kim S; Moon BI; Lim W; Park S; Cho MS; Sung SH
    Hum Pathol; 2016 Sep; 55():190-5. PubMed ID: 27184484
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Invasive ductal carcinoma of no special type and its corresponding lymph node metastasis: do they have the same immunophenotypic profile?
    Fulga V; Rudico L; Balica AR; Cimpean AM; Saptefrati L; Raica M
    Pol J Pathol; 2015 Mar; 66(1):30-7. PubMed ID: 26017877
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Utility of GATA3 in the differential diagnosis of pheochromocytoma.
    Perrino CM; Ho A; Dall CP; Zynger DL
    Histopathology; 2017 Sep; 71(3):475-479. PubMed ID: 28374498
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.
    Braxton DR; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2015 Apr; 43(4):271-7. PubMed ID: 25088841
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility.
    Banet N; Gown AM; Shih IeM; Kay Li Q; Roden RB; Nucci MR; Cheng L; Przybycin CG; Nasseri-Nik N; Wu LS; Netto GJ; Ronnett BM; Vang R
    Am J Surg Pathol; 2015 Jan; 39(1):101-8. PubMed ID: 25188865
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.
    Yuksel UM; Dilek G; Dogan L; Gulcelik MA; Berberoglu U
    Tumori; 2015; 101(2):194-8. PubMed ID: 25791533
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.
    Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS
    Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
    Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma.
    Liu LH; Siziopikou KP; Gabram S; McClatchey KD
    Arch Pathol Lab Med; 2000 Nov; 124(11):1670-3. PubMed ID: 11079022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls.
    Cimino-Mathews A
    Mod Pathol; 2021 Jan; 34(Suppl 1):62-77. PubMed ID: 33110239
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gynecologic Serous Carcinoma: An Immunohistochemical Analysis of Malignant Body Fluid Specimens.
    Ren S; Klump W
    Arch Pathol Lab Med; 2019 Jun; 143(6):677-682. PubMed ID: 29688031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.